English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Clinical Trials
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
Jul 29, 2025 04:00 HKT
亿胜生物多剂量地夸磷索钠滴眼液获中国国家药品监督管理局批准上市
Jul 25, 2025 10:52 HKT
億勝生物多劑量地誇磷索鈉滴眼液獲中國國家藥品監督管理局批准上市
Jul 25, 2025 10:52 HKT
Multi-Dose Diquafosol Sodium Eye Drops Obtained Approval from NMPA for Commercialisation in China
Jul 25, 2025 10:52 HKT
冠科生物圣地亚哥实验室获 CLIA 认证 增强临床试验支持能力
Jul 23, 2025 09:00 HKT
冠科生物聖地牙哥實驗室獲 CLIA 認證 增強臨床試驗支援能力
Jul 23, 2025 09:00 HKT
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets
Jul 22, 2025 13:00 HKT
康哲药业携手新交所 共话新兴市场产业国际化与医药出海新范式探索
Jul 18, 2025 13:00 HKT
耀啟新程!康哲藥業今日於新加坡交易所主板實現二次上市
Jul 15, 2025 17:05 HKT
耀启新程!康哲药业今日于新加坡交易所主板实现二次上市
Jul 15, 2025 16:53 HKT
Silo Pharma Enters Letter of Intent for JV with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

Jun 25, 2025 21:27 HKT
康哲藥業建議於新加坡交易所第二上市
Jun 25, 2025 18:13 HKT
康哲药业建议于新加坡交易所第二上市
Jun 25, 2025 17:24 HKT
康希諾重磅推出優佩欣疫苗 為兒童健康保駕護航的創新之選
Jun 21, 2025 12:09 HKT
康希诺重磅推出优佩欣疫苗 为儿童健康保驾护航的创新之选
Jun 20, 2025 17:58 HKT
Southeast Asian stem cell leader Medeze launches voluntary conditional cash partial offer for 10% stake in SGX-listed Cordlife Group Limited
May 14, 2025 15:00 HKT
HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025
Apr 24, 2025 18:43 HKT
君圣泰医药三项创新研究成果即将亮相2025欧肝会(EASL)
Apr 24, 2025 18:35 HKT
熊去氧胆小檗碱(HTD1801)一药多效 即将进入商业化新纪元
Apr 15, 2025 08:10 HKT
熊去氧膽小檗堿(HTD1801)一藥多效 即將進入商業化新紀元
Apr 15, 2025 08:10 HKT
Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: